Clinical Trial Update: Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating alemtuzumab for advanced mycosis fungoides and Sézary syndrome, with current status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Alemtuzumab (Campath) (alemtuzumab)

Snippet

Sponsor: Latin American Cooperative Onco-Haematology Group - Peru | Conditions: Mycosis Fungoides, Sezary Syndrome | Phase 2 | Status: UNKNOWN